Towards brain-controlled neuromodulation therapies to address gait and balance deficits in patients with Parkinson's disease

A Snapshot seminar hosted by the School of Physiology, Pharmacology and Neuroscience

Abstract: Impairments of gait and balance are amongst the most incapacitating and least well-understood symptoms of Parkinson's disease (PD). Well-established neuromodulation therapies for PD, which are highly effective for the treatment of upper-limb motor signs, often exhibit modest results to alleviate gait deficits. This discrepancy is presumably due to the divergence in the nature and dynamics of the circuits that control leg versus upper limb movements. To date, the brain signatures underlying leg motor function and dysfunction, their involvement in leg muscle recruitment and force modulation across locomotor activities, and their utility to help refine therapies remains unclear. Similarly, the impact of combining brain and spinal neuromodulation therapies to specifically address locomotor deficits remains controversial.

In this talk, I will present results on these two questions: First, we aimed to identify the neural correlates of leg force modulation from local field potentials recorded from deep brain stimulation electrodes implanted in the subthalamic nucleus of patients with PD, and to leverage this framework to develop decoding algorithms able to automatically predict leg force intention in real-time. Second, we employed brain-decoded intention to trigger and control spinal cord neuromodulation therapies during unconstrained movements in non-human primate model of PD. These combined results confirm the capacity to leverage brain signals to decode force production and leg motor intention in real-time, and to further exploit them to provide personalised therapies of brain and spinal cord to address gait deficits.